Delivery of ATRA and Gefitinib by Polyphenylalanine Nanosystem to Overcome EGFR-TKI Resistance in Lung Adenocarcinoma

被引：0
|
作者：
Liu, S. [1 ]
Zhou, H. [2 ]
Xu, B. [1 ]
Deng, J. [1 ]
Zeng, F. [2 ]
Qiu, H. [2 ]
机构：
[1] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Thorac Surg, Guangzhou, Peoples R China
[2] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Gen Practice, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Polyphenylalanine; EGFR-TKI resistance; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.08-04
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [21] Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
    Chung, Chi-Li
    Lee, Kai-Ling
    Hsiao, Shih-Hsin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [22] The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
    Chung, Fu-Tsai
    Ho, Ming-Yun
    Fang, Yueh-Fu
    Hshieh, Meng-Heng
    Wang, Tsai-Yu
    Kuo, Chih-Hsi
    Chen, Hao-Cheng
    Wang, Chun-Hwa
    Lin, Shu-Min
    Yu, Chih-Teng
    Lin, Horng-Chyuan
    Kuo, Han-Pin
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [23] Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI Resistance
    Ahn, Hyein
    Kwon, Hyun Jung
    Park, Eunhyang
    Kim, Hyojin
    Chung, Jin-Haeng
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (02) : 130 - 132
  • [24] Dual Inhibition of Met Kinase and Angiogenesis to Overcome HGF-Induced EGFR-TKI Resistance in EGFR Mutant Lung Cancer
    Takeuchi, Shinji
    Wang, Wei
    Li, Qi
    Yamada, Tadaaki
    Kita, Kenji
    Donev, Ivan S.
    Nakamura, Takahiro
    Matsumoto, Kunio
    Shimizu, Eiji
    Nishioka, Yasuhiko
    Sone, Saburo
    Nakagawa, Takayuki
    Uenaka, Toshimitsu
    Yano, Seiji
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (03): : 1034 - 1043
  • [25] Association between EGFR-TKI Resistance and Efficacy of Radiotherapy for Brain Metastases from EGFR-mutant Lung Adenocarcinoma
    Hirata, Hidenari
    Nakamura, Katsumasa
    Kunitake, Naonobu
    Shioyama, Yoshiyuki
    Sasaki, Tomonari
    Ohga, Saiji
    Nonoshita, Takeshi
    Yoshitake, Tadamasa
    Asai, Kaori
    Inoue, Kouji
    Nagashima, Akira
    Ono, Minoru
    Honda, Hiroshi
    ANTICANCER RESEARCH, 2013, 33 (04) : 1649 - 1655
  • [26] TARGETING THE HIPPO EFFECTOR YAP OVERCOMES THE RESISTANCE TO EGFR-TKI OF BOTH EGFR MUTATED AND KRAS MUTATED LUNG ADENOCARCINOMA
    Chung, Chaeuk
    Park, Dongil
    Kim, Ju Ock
    Park, Hee Sun
    Lee, Jeong Eun
    Moon, Jae Young
    Lim, Daesik
    Lee, Jaechul
    RESPIROLOGY, 2015, 20 : 102 - 102
  • [27] Management of patients with resistance to EGFR-TKI
    Barlesi, F.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2011, 67 : S30 - S35
  • [28] Liensinine overcomes EGFR-TKI resistance in lung adenocarcinoma through DRP1-mediated autophagy
    Chen, Yuling
    Shu, Chenying
    Yan, Zhaowei
    Zhang, Saiqun
    Zhang, Weijie
    Zhao, Jian
    Wang, Anqi
    Li, Jianjun
    Zeng, Yuanyuan
    Zhu, Jianjie
    Huang, Jian-an
    Liu, Zeyi
    PHYTOMEDICINE, 2025, 140
  • [29] EGFR-TKI rechallenged treatment combined with apatinib in non-small cell lung cancer with EGFR-TKI resistance.
    Liang, Li
    Li, Fang
    Cao, Baoshan
    Zhang, Zhaohui
    Zhu, Xiang
    Wang, Jiadong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance
    Dai, Chenyue
    Liu, Bing
    Li, Shaolei
    Hong, Yang
    Si, Jiahui
    Xiong, Ying
    Wu, Nan
    Ma, Yuanyuan
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
12345